Critical analysis of endomyocardial biopsies from patients suspected of having cardiomyopathy. I: Morphological and morphometric aspects - PubMed (original) (raw)
Critical analysis of endomyocardial biopsies from patients suspected of having cardiomyopathy. I: Morphological and morphometric aspects
U Baandrup et al. Br Heart J. 1981 May.
Abstract
Three hundred and sixty-one biopsies obtained by bioptome from 201 patients with suspected cardiomyopathy were analysed morphologically, semiquantitatively, quantitatively, and statistically to ascertain whether or not histological examination provided a measurable pattern characterising the different forms of cardiomyopathy. In addition, we have tried to find out whether or not morphometry increases the diagnostic reliability. Heart from 29 cases (10 female and 19 male) who died as a result of road traffic accidents or other extracardiac causes were sampled, selecting specimens from sites usually biopsied during life. Of these biopsies, 16.1 per cent were of such poor quality that morphological categorisation was not possible. The mean size of biopsies was 0.79 mm2, and on average 1.38 mm2 of tissue was available per patient. The histological descriptions were grouped in eight entities; morphometric analysis of the endocardium, myocardium, and interstitium resulted in a more accurate evaluation of the morphological changes. Muscle fibre diameter showed distinct variance between several morphological groups, particularly between normal and pathological groupings and between right and left sided ventricular samples. The applied scoring system included the histological HOCM index (hypertrophic cardiomyopathy) which separated clearly this type of cardiomyopathy from other disorders. Small foci of chronic inflammatory cells were seen in 25 per cent of the biopsies and did not indicate myocarditis. This study did not confirm the possible existence of small vessel disease. Morphometric data permitted distinction between several histological groups but this did not apply to individual patients in veiw of a considerable degree of overlap of the pathological changes. Combining the various morphological features and applying measurements failed to establish a definite pattern for congestive cardiomyopathy (COCM), and alcoholic heart muscle disease could not be separated from COCM. It is, however, suggested that semiquantitative and morphometric methods are mandatory, not only to define more accurately the morphological changes, but also to provide the basis for additional biochemical, immunological, and virological analysis.
Similar articles
- Critical analysis of endomyocardial biopsies from patients suspected of having cardiomyopathy. II: Comparison of histology and clinical/haemodynamic information.
Baandrup U, Florio RA, Rehahn M, Richardson PJ, Olsen EG. Baandrup U, et al. Br Heart J. 1981 May;45(5):487-93. doi: 10.1136/hrt.45.5.487. Br Heart J. 1981. PMID: 7195269 Free PMC article. - Right Ventricular endomyocardial biopsy: clinicopathologic correlates in 100 consecutive patients.
Nippoldt TB, Edwards WD, Holmes DR Jr, Reeder GS, Hartzler GO, Smith HC. Nippoldt TB, et al. Mayo Clin Proc. 1982 Jul;57(7):407-18. Mayo Clin Proc. 1982. PMID: 6211578 - The usefulness of an endomyocardial biopsy in heart disease of unknown etiology.
Fast JH, Kubat K, van Haelst UJ, Schuurmans Stekhoven JH. Fast JH, et al. Int J Cardiol. 1986 Jun;11(3):317-28. doi: 10.1016/0167-5273(86)90036-7. Int J Cardiol. 1986. PMID: 3013787 - The role of endomyocardial biopsy in the diagnosis of cardiac disorders in infants and children.
Chandra RS. Chandra RS. Am J Cardiovasc Pathol. 1987;1(2):157-72. Am J Cardiovasc Pathol. 1987. PMID: 3333138 Review. - Cardiomyopathies with particular reference to the diagnostic relevance of endomyocardial biopsies.
Becker AE. Becker AE. Wien Klin Wochenschr. 1988 Dec 16;100(24):787-91. Wien Klin Wochenschr. 1988. PMID: 3070965 Review.
Cited by
- A personalized mRNA signature for predicting hypertrophic cardiomyopathy applying machine learning methods.
Gu J, Zhao Y, Ben Y, Zhang S, Hua L, He S, Liu R, Chen X, Sheng H. Gu J, et al. Sci Rep. 2024 Jul 24;14(1):17023. doi: 10.1038/s41598-024-67201-8. Sci Rep. 2024. PMID: 39043774 Free PMC article. - Inflammation across the spectrum of hypertrophic cardiac phenotypes.
Lillo R, Graziani F, Franceschi F, Iannaccone G, Massetti M, Olivotto I, Crea F, Liuzzo G. Lillo R, et al. Heart Fail Rev. 2023 Sep;28(5):1065-1075. doi: 10.1007/s10741-023-10307-4. Epub 2023 Apr 28. Heart Fail Rev. 2023. PMID: 37115472 Free PMC article. Review. - Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Cats With Hypertrophic Cardiomyopathy.
Fries RC, Kadotani S, Stack JP, Kruckman L, Wallace G. Fries RC, et al. Front Vet Sci. 2022 Mar 14;9:813524. doi: 10.3389/fvets.2022.813524. eCollection 2022. Front Vet Sci. 2022. PMID: 35359679 Free PMC article. - In vivo calibration of the T2* cardiovascular magnetic resonance method at 1.5 T for estimation of cardiac iron in a minipig model of transfusional iron overload.
Jensen PD, Nielsen AH, Simonsen CW, Baandrup UT, Jensen SE, Bøgsted M, Magnusdottir SO, Jensen ABH, Kjaergaard B. Jensen PD, et al. J Cardiovasc Magn Reson. 2021 Mar 11;23(1):27. doi: 10.1186/s12968-021-00715-6. J Cardiovasc Magn Reson. 2021. PMID: 33691716 Free PMC article. - Systemic inflammation is associated with myocardial fibrosis, diastolic dysfunction, and cardiac hypertrophy in patients with hypertrophic cardiomyopathy.
Fang L, Ellims AH, Beale AL, Taylor AJ, Murphy A, Dart AM. Fang L, et al. Am J Transl Res. 2017 Nov 15;9(11):5063-5073. eCollection 2017. Am J Transl Res. 2017. PMID: 29218105 Free PMC article.
References
- Lancet. 1974 Apr;1(7859):658-60 - PubMed
- Dis Chest. 1963 Oct;44:345-50 - PubMed
- Med Lab Technol. 1971 Apr;28(2):148-9 - PubMed
- Cathet Cardiovasc Diagn. 1977;3(2):115-21 - PubMed
- Circulation. 1977 Mar;55(3):504-8 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical